新的细胞疗法为可能改善生存的T细胞白血病复发患者带来了希望。 New cell therapy offers hope to relapsed T-cell leukemia patients with potential survival improvement.

一种新的细胞疗法在治疗复发性或耐寒性T细胞白血病方面显示出希望,为那些对传统疗法没有反应的病人带来了希望。 A new cell therapy shows promise in treating relapsed or refractory T-cell leukemia, offering hope to patients who have not responded to traditional treatments. 治疗的目的是加强人体对癌症细胞的免疫反应,有可能提高存活率。 The therapy aims to enhance the body's immune response against cancer cells, potentially improving survival rates. 研究人员对它的有效性感到乐观,标志着白血病治疗方案取得了显著进步。 Researchers are optimistic about its effectiveness, marking a significant advancement in leukemia treatment options.